On March 1, 2024, Crinetics Pharmaceuticals, Inc closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.61 USD | +5.91% | +0.05% | +22.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.15% | 3.32B | |
+2.20% | 42.75B | |
+47.70% | 41.61B | |
+11.42% | 41.34B | |
-12.36% | 26.59B | |
+8.63% | 25.49B | |
-22.91% | 18.12B | |
+30.86% | 12.24B | |
-1.49% | 11.76B | |
+8.46% | 11B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals, Inc. announced that it has received $350.000028 million in funding from a group of investors